You are viewing an older, archived article. There may be more up to date articles on this subject, try a new search

COPD POEMs
Patient Oriented Evidence that Matters

Introduction COPD POEM PDF
Summary
The COPDX Plan
Confirm diagnosis & assess severity
Optimise function
Prevent deterioration
Develop support network & self-management plan
eXacerbations manage appropriately
Review of drug use in COPD
Appendix One - Resources and contacts
References

References

ATC, 2004. American Thoracic Society and European Respiratory Society; Standards for the diagnosis and management of patients with COPD. Available at: http://www.thoracic.org/sections/copd/resources/copddoc.pdf (Accessed March, 2005).

Bestall J C, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6.

Broad J, Jackson R. Chronic obstructive pulmonary disease and lung cancer in New Zealand. Report prepared for Thoracic Society of Australia and New Zealand. Oct 2003 updated Nov 2003.

Clinical Evidence, 12; 2004 Kerstjens HA, Postma DS. COPD. In: Clinical Evidence. Available at: http://www.clinicalevidence.com (Accessed March 2005).

Cooper CB, Tashkin DP. Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease. BMJ Mar 2005; 330:640-64.

Fishwick D, et al. Chronic Bronchitis, Shortness of Breath, and Airway Obstruction by Occupation in New Zealand. Am J Respir Crit Care Med 1997;156:1440-6.

Fletcher C, Petro, R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8.

GOLD, 2003 National Institutes of Health NHLaBI. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2003. Available at: http://www.goldcopd.com (Accessed 10 March 2005).

Jackson H, Hubbard R. Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey. BMJ 2003;327:653-4.

Jarad NA, et al. An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. Respir Med 1999;93:161-6.

NICE: National Institute for Clinical Excellence. Chronic obstructive pulmonary disease: National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1): 1-232. Available at: http://www.nice.org.uk/cat.asp?c=104441 (Accessed April 2005).

NZGG, 2002. Chronic Obstructive Pulmonary Disease (COPD). Australian and New Zealand Management Guidelines and the COPD Handbook, 2002. Available at: http://www.nzgg.org.nz/guidelines/dsp_guideline_popup.cfm?guidelineCatID=32&guidelineID=73 (Accessed 10 March 2005).

O'Brien A, et al. Effects of Withdrawal of Inhaled Steroids in Men with Severe Irreversible Airflow Obstruction. Am J Resir Crit Care Med 2001;164:365-71.

Prodigy COPD Guidelines, 2004. Available at: www.prodigy.nhs.uk. Now at www.cks.nhs.uk

Rennard SI, et al. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. Chest 1996;110:62-70.

The Asthma and Respiratory Foundation of New Zealand. Diagnosis & Treatment of COPD. Distributed to practitioners 2004.

The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52(Suppl 5):1-28. Available at: http://www.brit-thoracic.org.uk/docs/COPDtext.pdf (Accessed April 2005).


Page  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 Page 11